BioCentury
ARTICLE | Company News

Broad Institute, Albany Molecular Research deal

September 5, 2016 7:00 AM UTC

The institute granted Albany Molecular non-exclusive rights to IP related to CRISPR- Cas9. Albany Molecular will use the IP to enhance its drug discovery platform, which it provides as a service to cl...